The Impact of the COVID-19 Pandemic on People with Diabetes and Diabetes Services: A pan-European Survey of Diabetes Specialist Nurses undertaken by the Foundation of European Nurses in Diabetes survey consortium

Diabetes - General

Diabetes and COVID-19: psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark-what characterizes people with high levels of COVID-19-related worries?

Diabet Med.

Joensen LE, Madsen KP, Holm L, Nielsen KA, Rod MH, Petersen AA, Rod NH, Willaing I

doi: 10.1111/dme.14319.

Diabetes - General

Guidelines for the management of diabetes services and patients during the COVID-19 pandemic

Diabet Med.

Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, Voigt D, Courtney H, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland-Jones P, Stewart R, Burr O, Thomas S, London Inpatient Diabetes Network-COVID-19.

doi: 10.1111/dme.14316.

COMMENTED

Type 1 DiabetesType 2 DiabetesDiabetic Complications

COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes

★ 2 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

Diabetes Care

Gregory JM, Slaughter JC, Duffus SH, Smith TJ, LeStourgeon LM, Jaser SS, McCoy AB, Luther JM, Giovannetti ER, Boeder S, Pettus JH, Moore DJ

doi: 10.2337/dc20-2260

COMMENTED

Type 1 DiabetesType 2 Diabetes

Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

★ 2 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

Lancet Diabetes Endocrinol.

Holman N, Knighton P, Kar P, O'Keefe J, Curley M, Weaver A, Barron E, Bakhai C, Khunti K, Wareham NJ, Sattar N, Young B, Valabhji J

doi: 10.1016/S2213-8587(20)30271-0.

Type 1 DiabetesDiabetic ComplicationsGenetic Aspects of Diabetes

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

Lancet Diabetes Endocrinol

McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, Hutchinson S, Caparrotta TM, Mellor J, Jeyam A, O'Reilly JE, Wild SH, Hatam S, Höhn A, Colombo M, Robertson C, Lone N, Murray J, Butterly E, Petrie J, Kennon B, McCrimmon R, Lindsay R, Pearson E, Sattar N, McKnight J, Philip S, Collier A, McMenamin J, Smith-Palmer A, Goldberg D, McKeigue PM, Colhoun HM, Public Health Scotland COVID-19 Health Protection Study Group., Scottish Diabetes Research Network Epidemiology Group.

doi: 10.1016/S2213-8587(20)30405-8

COMMENTED

Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

doi: 10.2337/dc20-0941.

Diabetes - General

Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters

Diabetes Care.

Hartmann-Boyce J, Morris E, Goyder C, Kinton J, Perring J, Nunan D, Mahtani K, Buse JB, Del Prato S, Ji L, Roussel R, Khunti K

doi: 10.2337/dc20-1192.

Diabetic Complications

Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic: Letter

doi: 10.1111/dme.14328.

Type 2 Diabetes

Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study

Diabetes Obes Metab.

Fadini GP, Morieri ML, Longato E, Bonora BM, Pinelli S, Selmin E, Voltan G, Falaguasta D, Tresso S, Costantini G, Sparacino G, Di Camillo B, Tramontan L, Cattelan AM, Vianello A, Fioretto P, Vettor R, Avogaro A

doi: 10.1111/dom.14097.

Related content

Diabetes and COVID-19: psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark-what characterizes people with high levels of COVID-19-related worries?

Guidelines for the management of diabetes services and patients during the COVID-19 pandemic

COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes

Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era

Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters

Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic: Letter

Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study